Company

VistaGen Therapeutics

As of the edition of 20 October 2026, VistaGen Therapeutics runs 2 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active1
Stopped1
Total2

Where its trials are

  • Mental health: 7 trials led
  • Nervous system: 2 trials led
  • Chemically induced: 1 trials led